Reopened Chinese hearing aid market is difficult to predict, says Demant CEO
Though pent-up demand in China is a given after pandemic restrictions have lapsed, a number of factors make it difficult to assess the actual potential, says Demant CEO Søren Nielsen.
by albert rønning-andersson, translated by daniel pedersen
Hearing aid manufacturer Demant had an awful 2022 in China, and a pretty tough start to 2023 in the country as well. After a domestic zero-tolerance Covid-19 policy was dropped in December, though, things are somewhat improving, says Chief Executive Søren Nielsen to MedWatch.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Demant CEO takes pay cut following bottom-line drop in 2022
For subscribers
